CELC Celcuity Inc.
Price Chart
Executive Summary
Celcuity is offering $400M in convertible senior notes due 2032 (with a $60M over-allotment option). Proceeds will repay $137.9M in secured term loans under the A&R Loan Agreement, with the remainder for working capital and general corporate purposes including clinical trials and commercial launch. The filing is preliminary with placeholder interest rate and conversion price, but the $400M size and debt-for-debt swap (secured to unsecured) are material.
Actionable Insight
The $400M convertible note offering adds significant leverage and future dilution risk. Monitor the final conversion price and interest rate in the priced prospectus supplement. The debt-for-debt swap (secured to unsecured) improves balance sheet flexibility but at the cost of higher total debt. Watch for potential stock price pressure from convertible arbitrage hedging by note purchasers.
Key Facts
- $400M aggregate principal amount of convertible senior notes due 2032 (up to $460M with over-allotment)
- Proceeds to repay $137.9M in secured term loans under the A&R Loan Agreement (as of March 31, 2026)
- Total long-term debt would increase from $339.1M to $601.3M pro forma (as of March 31, 2026)
- Notes are unsecured senior obligations, ranking equal with existing $201.25M 2.750% Convertible Senior Notes due 2031
- Conversion price and interest rate are placeholders (TBD in final prospectus supplement)
- Stock price on June 2, 2026: $91.42 per share
- Underwriters include Jefferies, J.P. Morgan, TD Cowen, Guggenheim Securities, LifeSci Capital, Craig-Hallum, Wolfe | Nomura Alliance
Financial Impact
$400M debt issuance increases total long-term debt from $339.1M to $601.3M (77% increase); $137.9M secured debt eliminated, replaced by unsecured convertible notes
Risk Factors
- Dilution from potential conversion of notes into common stock (conversion price TBD but likely at a premium to current $91.42 stock price)
- Increased interest expense from $400M in new debt; cash interest payments will reduce cash runway
- Stock price decline risk from convertible arbitrage short selling by note investors
- No established trading market for the notes; liquidity risk for noteholders
- Pro forma leverage increases significantly; may constrain future financing flexibility
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-026972 |
| Document: 0001493152-26-026972-index-headers.html | 0001493152-26-026972 |
| Document: 0001493152-26-026972-index.html | 0001493152-26-026972 |
| Document: 0001493152-26-026972.txt | 0001493152-26-026972 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
today
|
424B5
| — | awaiting T+1 | — | — |
|
Jun 4, 2026
1d ago
|
Press Release
| — | awaiting T+1 | — | — |
|
Jun 3, 2026
2d ago
|
Press Release
| $88.95 $92.47 | ▼ −3.96% | ▼ −3.56% | $88.28 (+0.75%) |
|
Jun 3, 2026
2d ago
|
424B5
| $88.95 $92.47 | ▼ −3.96% | ▼ −3.56% | $88.28 (+0.75%) |
|
Jun 2, 2026
3d ago
|
8-K
| $91.42 $88.95 | ▼ −2.70% | ▼ −2.01% | $88.28 (−3.43%) |
|
May 14, 2026
22d ago
|
Press Release
| $137.68 $132.18 | ▼ −3.99% | ▼ −3.93% | $88.28 (−35.88%) |
|
May 7, 2026
29d ago
|
Press Release
| $130.71 $131.06 | ▲ +0.27% | ▼ −0.56% | $88.28 (−32.46%) |
|
May 4, 2026
4w ago
|
144
| $144.98 $141.69 | ▼ −2.27% | ▼ −3.06% | $88.28 (−39.11%) |
|
May 1, 2026
5w ago
|
Press Release
| $144.98 $141.69 | ▼ −2.27% | ▼ −3.06% | $88.28 (−39.11%) |
|
Mar 25, 2026
10w ago
|
Press Release
| $114.81 $106.02 | ▼ −7.66% | ▼ −5.98% | $88.28 (−23.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access